EICHOR
● Completed
A Study of Palbociclib (PD-0332991) + Letrozole vs. Letrozole For 1st Line Treatment Of Postmenopausal Women With ER+/HER2- Advanced Breast Cancer (PALOMA-2)
Condition: Breast Neoplasms · Sponsor: Pfizer
About this study
The study is designed to compare the clinical benefit following treatment with letrozole in combination with PD-0332991 versus letrozole in combination with placebo in postmenopausal women with ER(+)/HER2(-) advanced breast cancer who have not received prior systemic anti cancer therapies for their advanced/metastatic disease.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (305)
| Southern California Permanente Medical Group | Bellflower, California, United States | — |
| Beverly Hills Cancer Center | Beverly Hills, California, United States | — |
| St. Joseph Heritage Healthcare | Fullerton, California, United States | — |
| Los Angeles Hematology/Oncology Medical Group | Glendale, California, United States | — |
| UCLA Hematology/ Oncology- Irvine | Irvine, California, United States | — |
| UCLA Hematology Oncology- Laguna Hills | Laguna Hills, California, United States | — |
| Los Angeles Hematology/Oncology Medical Group | Los Angeles, California, United States | — |
| Southern California Permanente Medical Group | Los Angeles, California, United States | — |
| Translational Research Management | Los Angeles, California, United States | — |
| Drug Management Only: UCLA West Medical Pharmacy, Attn: Steven L Wong, Pharm.D. | Los Angeles, California, United States | — |
| UCLA West Medical Pharmacy, Attn: Steven L. Wong | Los Angeles, California, United States | — |
| UCLA West Medical Pharmacy: Drug Management Only | Los Angeles, California, United States | — |
+ 293 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT01740427